Judd et al.11 have shown that the administration of recombinant IL-33 for 1 week in wild-type mice results in very similar histological changes in the esophagus as seen in human early EoE; these histological changes were ablated in IL-13-deficient mice. Here, IL13 is linked to eosinophilic esophagitis.